Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 2 | 113131068 | stop gained | G/T | snv | 3.2E-05 | 7.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases | 0.700 | 0 | |||||||||
|
1.000 | 0.080 | 2 | 113129619 | stop gained | C/T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases | 0.700 | 0 | |||||||||||
|
0.851 | 0.080 | 2 | 113131082 | synonymous variant | G/A | snv | 4.0E-06 |
|
Digestive System Diseases | 0.010 | < 0.001 | 1 | 2012 | 2012 | |||||||
|
0.851 | 0.080 | 2 | 113131082 | synonymous variant | G/A | snv | 4.0E-06 |
|
Digestive System Diseases | 0.010 | < 0.001 | 1 | 2013 | 2013 | |||||||
|
0.851 | 0.080 | 2 | 113131082 | synonymous variant | G/A | snv | 4.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.010 | < 0.001 | 1 | 2012 | 2012 | |||||||
|
0.851 | 0.080 | 2 | 113131082 | synonymous variant | G/A | snv | 4.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.010 | < 0.001 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 2 | 113128926 | intron variant | G/A | snv | 0.21 |
|
Mental Disorders | 0.010 | < 0.001 | 1 | 2010 | 2010 | |||||||
|
0.716 | 0.480 | 2 | 113130529 | intron variant | ATCCTGGGGAAAGTGAGGGAAATATGGACATCACATGGAACAACATCCAGGAGACTCAGGCCTCTAGGAGTAACTGGGTAGTGTGCATCCTGGGGAAAGTGAGGGAAATATGGACATCACATGGAACAACATCCAGGAGACTCAGGCCTCTAGGAGTAACTGGGTAGTGTGC/-;ATCCTGGGGAAAGTGAGGGAAATATGGACATCACATGGAACAACATCCAGGAGACTCAGGCCTCTAGGAGTAACTGGGTAGTGTGC;ATCCTGGGGAAAGTGAGGGAAATATGGACATCACATGGAACAACATCCAGGAGACTCAGGCCTCTAGGAGTAACTGGGTAGTGTGCATCCTGGGGAAAGTGAGGGAAATATGGACATCACATGGAACAACATCCAGGAGACTCAGGCCTCTAGGAGTAACTGGGTAGTGTGCATCCTGGGGAAAGTGAGGGAAATATGGACATCACATGGAACAACATCCAGGAGACTCAGGCCTCTAGGAGTAACTGGGTAGTGTGC;ATCCTGGGGAAAGTGAGGGAAATATGGACATCACATGGAACAACATCCAGGAGACTCAGGCCTCTAGGAGTAACTGGGTAGTGTGCATCCTGGGGAAAGTGAGGGAAATATGGACATCACATGGAACAACATCCAGGAGACTCAGGCCTCTAGGAGTAACTGGGTAGTGTGCATCCTGGGGAAAGTGAGGGAAATATGGACATCACATGGAACAACATCCAGGAGACTCAGGCCTCTAGGAGTAACTGGGTAGTGTGCATCCTGGGGAAAGTGAGGGAAATATGGACATCACATGGAACAACATCCAGGAGACTCAGGCCTCTAGGAGTAACTGGGTAGTGTGC | delins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 0.010 | < 0.001 | 1 | 2016 | 2016 | ||||||||
|
0.925 | 0.080 | 2 | 113117988 | 5 prime UTR variant | A/G | snv | 0.25 | 0.21 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | < 0.001 | 1 | 2007 | 2007 | ||||||
|
0.763 | 0.400 | 2 | 113132727 | missense variant | T/A;C | snv | 4.0E-06; 0.31 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Mental Disorders | 0.010 | < 0.001 | 1 | 2015 | 2015 | |||||||
|
0.763 | 0.400 | 2 | 113132727 | missense variant | T/A;C | snv | 4.0E-06; 0.31 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | < 0.001 | 1 | 2006 | 2006 | |||||||
|
0.763 | 0.400 | 2 | 113132727 | missense variant | T/A;C | snv | 4.0E-06; 0.31 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.020 | 0.500 | 2 | 2006 | 2013 | |||||||
|
0.763 | 0.400 | 2 | 113132727 | missense variant | T/A;C | snv | 4.0E-06; 0.31 |
|
Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2013 | 2014 | |||||||
|
2 | 113108257 | intron variant | A/C | snv | 0.35 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
2 | 113130226 | intron variant | A/G | snv | 0.21 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
2 | 113108948 | intron variant | G/A | snv | 0.28 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.080 | 2 | 113132708 | missense variant | C/G | snv | 7.0E-06 |
|
Nutritional and Metabolic Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2002 | 2002 | |||||||
|
2 | 113112226 | intron variant | C/G;T | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
1.000 | 0.120 | 2 | 113100619 | regulatory region variant | C/A | snv | 0.91 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
2 | 113128807 | intron variant | A/G | snv | 0.74 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.040 | 2 | 113128926 | intron variant | G/A | snv | 0.21 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
1.000 | 0.080 | 2 | 113131111 | missense variant | G/T | snv | 2.1E-04 | 2.5E-04 |
|
Infections; Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
|
2 | 113106194 | upstream gene variant | T/C | snv | 0.56 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
2 | 113106194 | upstream gene variant | T/C | snv | 0.56 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
2 | 113106194 | upstream gene variant | T/C | snv | 0.56 |
|
0.700 | 1.000 | 1 | 2016 | 2016 |